Changes in fat and lean mass may influence motor function, frailty, and disease progression
Your physician will monitor you regularly to assess both safety and effectiveness
More serious but rare risks involve low blood sugar, gallstones, and pancreatitis
They address both metabolic issues and excess body weight
Although metformin increased GLP-1R level, exendin (939) or GLP-1R siRNA did not attenuate the protective effects of metformin in PA-impaired HUVECs, suggesting that metformin per se could not exert protective effects via GLP-1R, instead, metformin upregulated GLP-1R to enhance the protective effects of liraglutide on endothelial function
Cancer Cell 34 , 2143 (2018)